{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:10:34Z","timestamp":1788480634623,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Guangxi Province","award":["No. 2024GXNSFAA010036"],"award-info":[{"award-number":["No. 2024GXNSFAA010036"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82460662"],"award-info":[{"award-number":["No. 82460662"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Innovation Project of Guangxi Graduate Education","award":["No. YCSW2024445"],"award-info":[{"award-number":["No. YCSW2024445"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55516-7","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:54:53Z","timestamp":1780127693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TLCD1 correlates with malignant progression of hepatocellular carcinoma and activation of the ERK signaling cascade"],"prefix":"10.1038","volume":"16","author":[{"given":"Pei","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Bei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"55516_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou, M. et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London England). 394, 1145\u20131158 (2019).","journal-title":"Lancet (London England)"},{"key":"55516_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","volume":"406","author":"SL Chan","year":"2025","unstructured":"Chan, S. L. et al. The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. Lancet (London England). 406, 731\u2013778 (2025).","journal-title":"Lancet (London England)"},{"key":"55516_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"Cancer J. Clin."},{"key":"55516_CR4","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han, B. et al. Cancer incidence and mortality in China, 2022. J. Natl. Cancer Cent. 4, 47\u201353 (2024).","journal-title":"J. Natl. Cancer Cent."},{"key":"55516_CR5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41571-023-00816-4","volume":"20","author":"TF Greten","year":"2023","unstructured":"Greten, T. F. et al. Biomarkers for immunotherapy of hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 20, 780\u2013798 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"55516_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet, J. M. et al. Immunotherapies for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 19, 151\u2013172 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"55516_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","volume":"77","author":"AG Singal","year":"2022","unstructured":"Singal, A. G. et al. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis. J. Hepatol. 77, 128\u2013139 (2022).","journal-title":"J. Hepatol."},{"key":"55516_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","volume":"79","author":"N Yahoo","year":"2023","unstructured":"Yahoo, N., Dudek, M., Knolle, P. & Heikenw\u00e4lder, M. Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation. J. Hepatol. 79, 538\u2013551 (2023).","journal-title":"J. Hepatol."},{"key":"55516_CR9","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1038\/s41467-022-33735-6","volume":"13","author":"K Petkevicius","year":"2022","unstructured":"Petkevicius, K. et al. TLCD1 and TLCD2 regulate cellular phosphatidylethanolamine composition and promote the progression of non-alcoholic steatohepatitis. Nat. Commun. 13, 6020 (2022).","journal-title":"Nat. Commun."},{"key":"55516_CR10","doi-asserted-by":"publisher","first-page":"eadr3723","DOI":"10.1126\/sciadv.adr3723","volume":"11","author":"PK Sheokand","year":"2025","unstructured":"Sheokand, P. K. et al. TRAM-LAG1-CLN8 family proteins are acyltransferases regulating phospholipid composition. Sci. Adv. 11, eadr3723 (2025).","journal-title":"Sci. Adv."},{"key":"55516_CR11","doi-asserted-by":"publisher","first-page":"1305906","DOI":"10.3389\/fcell.2023.1305906","volume":"11","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Multi-omics analysis of TLCD1 as a promising biomarker in pan-cancer. Front. cell. Dev. biology. 11, 1305906 (2023).","journal-title":"Front. cell. Dev. biology"},{"key":"55516_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12885-024-12364-w","volume":"24","author":"Y Du","year":"2024","unstructured":"Du, Y. et al. Methylation-regulated tumor suppressor gene PDE7B promotes HCC invasion and metastasis through the PI3K\/AKT signaling pathway. BMC cancer. 24, 624 (2024).","journal-title":"BMC cancer"},{"key":"55516_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello, M. & Roux, P. P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. biology reviews: MMBR. 75, 50\u201383 (2011).","journal-title":"Microbiol. Mol. biology reviews: MMBR"},{"key":"55516_CR14","doi-asserted-by":"publisher","first-page":"a011254","DOI":"10.1101\/cshperspect.a011254","volume":"4","author":"DK Morrison","year":"2012","unstructured":"Morrison, D. K. MAP kinase pathways. Cold Spring Harb. Perspect. Biol. 4, a011254 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"55516_CR15","doi-asserted-by":"publisher","first-page":"11551","DOI":"10.1038\/ncomms11551","volume":"7","author":"PR de Jong","year":"2016","unstructured":"de Jong, P. R. et al. ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1\/2 abrogation. Nat. Commun. 7, 11551 (2016).","journal-title":"Nat. Commun."},{"key":"55516_CR16","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.biopha.2018.09.036","volume":"108","author":"Y Teng","year":"2018","unstructured":"Teng, Y., Guo, B., Mu, X. & Liu, S. KIF26B promotes cell proliferation and migration through the FGF2\/ERK signaling pathway in breast cancer. Biomed. Pharmacother. 108, 766\u2013773 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"55516_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner, E. F. & Nebreda, A. R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer. 9, 537\u2013549 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"55516_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12906-023-04306-z","volume":"24","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Shikonin reactivates TSGs GADD45B and PPP3CC to block NSCLC cell proliferation and migration through JNK\/P38\/MAPK signaling pathways. BMC Complement. Med. Ther. 24, 10 (2024).","journal-title":"BMC Complement. Med. Ther."},{"key":"55516_CR19","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1002\/jcb.26625","volume":"119","author":"Z Liu","year":"2018","unstructured":"Liu, Z., Chen, D., Ning, F., Du, J. & Wang, H. EGF is highly expressed in hepatocellular carcinoma (HCC) and promotes motility of HCC cells via fibronectin. J. Cell. Biochem. 119, 4170\u20134183 (2018).","journal-title":"J. Cell. Biochem."},{"key":"55516_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","volume":"66","author":"R Roskoski Jr","year":"2012","unstructured":"Roskoski, R. Jr. ERK1\/2 MAP kinases: structure, function, and regulation. Pharmacol. Res. 66, 105\u2013143 (2012).","journal-title":"Pharmacol. Res."},{"key":"55516_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41419-022-04796-8","volume":"13","author":"S Song","year":"2022","unstructured":"Song, S. et al. EGFR\/MET promotes hepatocellular carcinoma metastasis by stabilizing tumor cells and resisting to RTKs inhibitors in circulating tumor microemboli. Cell Death Dis. 13, 351 (2022).","journal-title":"Cell Death Dis."},{"key":"55516_CR22","doi-asserted-by":"publisher","first-page":"734750","DOI":"10.3389\/fcimb.2021.734750","volume":"11","author":"C Wang","year":"2021","unstructured":"Wang, C., He, Q., Yin, Y., Wu, Y. & Li, X. Clonorchis sinensis Granulin Promotes Malignant Transformation of Hepatocyte Through EGFR-Mediated RAS\/MAPK\/ERK and PI3K\/Akt Signaling Pathways. Front. Cell. Infect. Microbiol. 11, 734750 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"55516_CR23","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.3390\/cancers13123026","volume":"13","author":"H Moon","year":"2021","unstructured":"Moon, H. & Ro, S. W. MAPK\/ERK Signaling Pathway in Hepatocellular Carcinoma. Cancers 13, 3026 (2021).","journal-title":"Cancers"},{"key":"55516_CR24","doi-asserted-by":"publisher","first-page":"107016","DOI":"10.5306\/wjco.v16.i6.107016","volume":"16","author":"D Hu","year":"2025","unstructured":"Hu, D. et al. Comparison and trend analysis of cancer incidence in China and globally in 2022. World J. Clin. Oncol. 16, 107016 (2025).","journal-title":"World J. Clin. Oncol."},{"key":"55516_CR25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia, C. et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin. Med. J. 135, 584\u2013590 (2022).","journal-title":"Chin. Med. J."},{"key":"55516_CR26","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3390\/biomedicines13051244","volume":"13","author":"C Li","year":"2025","unstructured":"Li, C., Lu, B. & Deng, B. New Insights into the Diagnosis and Treatment of Hepatocellular Carcinoma. Biomedicines 13, 1244 (2025).","journal-title":"Biomedicines"},{"key":"55516_CR27","doi-asserted-by":"publisher","first-page":"2493457","DOI":"10.1080\/20450923.2025.2493457","volume":"12","author":"M Akabane","year":"2025","unstructured":"Akabane, M., Imaoka, Y., Kawashima, J. & Pawlik, T. M. Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapy. Hepatic Oncol. 12, 2493457 (2025).","journal-title":"Hepatic Oncol."},{"key":"55516_CR28","doi-asserted-by":"publisher","first-page":"104735","DOI":"10.1016\/j.critrevonc.2025.104735","volume":"211","author":"X Ye","year":"2025","unstructured":"Ye, X., Fang, X., Li, F. & Jin, D. Targeting TIME in advanced hepatocellular carcinoma: Mechanisms of drug resistance and treatment strategies. Crit. Rev. Oncol. Hematol. 211, 104735 (2025).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"55516_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12920-025-02195-4","volume":"18","author":"X Li","year":"2025","unstructured":"Li, X., Xing, X., Wang, L. & Li, S. Arsenic sulfide alleviates the progression of liver cancer malignancy by inhibiting the expression of TLCD1 in mice. BMC Med. Genom. 18, 128 (2025).","journal-title":"BMC Med. Genom."},{"key":"55516_CR30","doi-asserted-by":"crossref","unstructured":"Cai, M. et al. Identification and Validation of a Necroptosis-Related Prognostic Signature for Kidney Renal Clear Cell Carcinoma. Stem cells international 8446765 (2023). (2023).","DOI":"10.1155\/2023\/8446765"},{"key":"55516_CR31","doi-asserted-by":"publisher","first-page":"561566","DOI":"10.3389\/fgene.2020.561566","volume":"11","author":"L Sang","year":"2020","unstructured":"Sang, L., Sun, L., Wang, A., Zhang, H. & Yuan, Y. The N6-Methyladenosine Features of mRNA and Aberrant Expression of m6A Modified Genes in Gastric Cancer and Their Potential Impact on the Risk and Prognosis. Front. Genet. 11, 561566 (2020).","journal-title":"Front. Genet."},{"key":"55516_CR32","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.1002\/jcb.28151","volume":"120","author":"Y Li","year":"2019","unstructured":"Li, Y., Yang, X., Yang, J., Wang, H. & Wei, W. An 11-gene-based prognostic signature for uveal melanoma metastasis based on gene expression and DNA methylation profile. J. Cell. Biochem. 120, 8630\u20138639 (2019).","journal-title":"J. Cell. Biochem."},{"key":"55516_CR33","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.3390\/cancers16152614","volume":"16","author":"C Keim-Del","year":"2024","unstructured":"Keim-Del, C., Pino, P., Ramos-Garc\u00eda, M. & Gonz\u00e1lez-Moles A Molecular Hypothesis on Malignant Transformation of Oral Lichen Planus: A Systematic Review and Meta-Analysis of Cancer Hallmarks Expression in This Oral Potentially Malignant Disorder. Cancers 16, 2614 (2024).","journal-title":"Cancers"},{"key":"55516_CR34","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"55516_CR35","doi-asserted-by":"publisher","first-page":"107221","DOI":"10.1016\/j.compbiomed.2023.107221","volume":"164","author":"T Lazebnik","year":"2023","unstructured":"Lazebnik, T. & Simon-Keren, L. Cancer-inspired genomics mapper model for the generation of synthetic DNA sequences with desired genomics signatures. Comput. Biol. Med. 164, 107221 (2023).","journal-title":"Comput. Biol. Med."},{"key":"55516_CR36","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/biology13100753","volume":"13","author":"A Alfahed","year":"2024","unstructured":"Alfahed, A. Cell Migration-Proliferation Dichotomy in Cancer: Biological Fact or Experimental Artefact? Biology 13, 753 (2024).","journal-title":"Biology"},{"key":"55516_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1568009023333872","volume":"2","author":"Y Liang","year":"2002","unstructured":"Liang, Y., McDonnell, S. & Clynes, M. Examining the relationship between cancer invasion\/metastasis and drug resistance. Curr. Cancer Drug Targets. 2, 257\u2013277 (2002).","journal-title":"Curr. Cancer Drug Targets"},{"key":"55516_CR38","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/JHC.S544589","volume":"12","author":"QB Wang","year":"2025","unstructured":"Wang, Q. B. et al. Tumor Compression of the Hepatic or Portal Vein Predicts the Presence of Microvascular Invasion and Satellite Nodules in Hepatocellular Carcinoma: A Retrospective Study. J. hepatocellular carcinoma. 12, 2055\u20132067 (2025).","journal-title":"J. hepatocellular carcinoma"},{"key":"55516_CR39","doi-asserted-by":"publisher","first-page":"101980","DOI":"10.1016\/j.smim.2025.101980","volume":"79","author":"MG Fernandez-Barrena","year":"2025","unstructured":"Fernandez-Barrena, M. G., Uriarte, I., Sarobe, P. & Avila, M. A. Epigenetic mechanisms in HCC immune landscape: Therapeutic implications. Semin. Immunol. 79, 101980 (2025).","journal-title":"Semin. Immunol."},{"key":"55516_CR40","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41416-025-02969-8","volume":"132","author":"HY Lin","year":"2025","unstructured":"Lin, H. Y. et al. The epigenetic basis of hepatocellular carcinoma - mechanisms and potential directions for biomarkers and therapeutics. Br. J. Cancer. 132, 869\u2013887 (2025).","journal-title":"Br. J. Cancer"},{"key":"55516_CR41","doi-asserted-by":"publisher","first-page":"2421231","DOI":"10.1080\/21505594.2024.2421231","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma. Virulence 15, 2421231 (2024).","journal-title":"Virulence"},{"key":"55516_CR42","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1158\/2159-8290.CD-20-0187","volume":"10","author":"V Amodio","year":"2020","unstructured":"Amodio, V. et al. Blockade Reverts Resistance to KRAS(G12C) Inhibition in Colorectal Cancer. Cancer Discov. 10, 1129\u20131139 (2020).","journal-title":"Cancer Discov."},{"key":"55516_CR43","doi-asserted-by":"publisher","first-page":"eade1155","DOI":"10.1126\/sciadv.ade1155","volume":"9","author":"Q Jiang","year":"2023","unstructured":"Jiang, Q. et al. HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis. Sci. Adv. 9, eade1155 (2023).","journal-title":"Sci. Adv."},{"key":"55516_CR44","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.7150\/thno.79493","volume":"13","author":"K Rubio","year":"2023","unstructured":"Rubio, K. et al. Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer. Theranostics 13, 2384\u20132407 (2023).","journal-title":"Theranostics"},{"key":"55516_CR45","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1017\/S0007114507879128","volume":"99","author":"W Sun","year":"2008","unstructured":"Sun, W. et al. \u03b3-Tocotrienol-induced apoptosis in human gastric cancer SGC-7901 cells is associated with a suppression in mitogen-activated protein kinase signalling. Br. J. Nutr. 99, 1247\u20131254 (2008).","journal-title":"Br. J. Nutr."},{"key":"55516_CR46","doi-asserted-by":"publisher","first-page":"e0318232","DOI":"10.1371\/journal.pone.0318232","volume":"20","author":"J Li","year":"2025","unstructured":"Li, J. et al. A clinical study exploring the prediction of microvascular invasion in hepatocellular carcinoma through the use of combined enhanced CT and MRI radiomics. PloS one. 20, e0318232 (2025).","journal-title":"PloS one"},{"key":"55516_CR47","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/JHC.S556306","volume":"12","author":"WL Luo","year":"2025","unstructured":"Luo, W. L. et al. Impact of Middle Hepatic Vein Resection During Hemihepatectomy on Surgical Outcomes and Long-Term Prognosis in Hepatocellular Carcinoma: A Retrospective Study. J. hepatocellular carcinoma. 12, 2681\u20132692 (2025).","journal-title":"J. hepatocellular carcinoma"},{"key":"55516_CR48","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55516-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:03:51Z","timestamp":1786367031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55516-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55516"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55516-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the First Affiliated Hospital of Guilin Medical University, Guangxi, China (Approval No. GYLL2022037). All participants provided written informed consent.","order":2,"name":"Ethics","label":"Ethics declarations","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24702"}}